Enphase Energy Inc vs Zoetis Inc — how do they compare? Enphase Energy Inc trades at $32.7 (market cap $4.35B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 6.9× Enphase Energy Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Zoetis Inc for 70 Days on average.
| ENPH | ZTS | |
|---|---|---|
Market Cap | $4.35B | $30.20B |
Volume | 5,068,595 | 6,175,327 |
Sector | Energy | Health |
52-Week High | $72.33 | $147.53 |
52-Week Low | $26.12 | $69.09 |
Typical Hold Time | 72 Days | 70 Days |
Enterprise Value | $3.99B | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.81, down 2.06% on the day, with a bearish technical signal from moving averages and mixed recent earnings. The company reported revenue of $1.47B and net income of $172.13M for 2025, with a P/E ratio of 32.58. Recent news highlights product approvals and manufacturing milestones for AI data center power solutions, though the solar sector faces headwinds from high borrowing costs.
The outlook is cautious; while analyst consensus is a Buy with a $42.90 price target, near-term risks include sector volatility and recent earnings misses. Long-term opportunities hinge on execution in the energy technology and AI infrastructure markets, but investors should weigh competitive pressures and macroeconomic factors affecting solar project financing.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →